Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1998-12-21
|
pubmed:abstractText |
Mutations in the gene for presenilin 1 are causative for the majority of cases of early onset familial Alzheimer's disease. Yet, the physiological function of presenilin 1 and the pathological mechanisms of the mutations leading to Alzheimer's disease are still unknown. To analyse potential pathological effects of presenilin 1 over-expression, we have generated transgenic rats which express high levels of human presenilin 1 protein in the brain. The over-expression of presenilin 1 leads to saturation of its normal processing and to the appearance of full-length protein in the transgenic rat brain. The transgenic protein is expressed throughout the brain and is predominantly found in neuronal cells. Cultured primary cortical neurons derived from these transgenic rats are significantly more sensitive than non-transgenic controls to apoptosis induced by standard culture conditions and to apoptosis induced by trophic factor withdrawal. Furthermore, the observed apoptosis is directly correlated with the expression of the transgenic protein. The results further emphasize the role of presenilin 1 in apoptotic cell death in native neuronal cultures.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0306-4522
|
pubmed:author |
pubmed-author:BlanchardVV,
pubmed-author:BonicaJJ,
pubmed-author:CarpentierNN,
pubmed-author:CzechCC,
pubmed-author:DreislerSS,
pubmed-author:HugonJJ,
pubmed-author:LesortMM,
pubmed-author:MoussaouiSS,
pubmed-author:PradierLL,
pubmed-author:SchombertBB,
pubmed-author:TakashimaAA,
pubmed-author:TerreLL,
pubmed-author:TrendPP
|
pubmed:issnType |
Print
|
pubmed:volume |
87
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
325-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9740395-Alzheimer Disease,
pubmed-meshheading:9740395-Animals,
pubmed-meshheading:9740395-Animals, Genetically Modified,
pubmed-meshheading:9740395-Apoptosis,
pubmed-meshheading:9740395-Blotting, Northern,
pubmed-meshheading:9740395-Blotting, Western,
pubmed-meshheading:9740395-Cells, Cultured,
pubmed-meshheading:9740395-Female,
pubmed-meshheading:9740395-Humans,
pubmed-meshheading:9740395-Immunohistochemistry,
pubmed-meshheading:9740395-Membrane Proteins,
pubmed-meshheading:9740395-Neurons,
pubmed-meshheading:9740395-Presenilin-1,
pubmed-meshheading:9740395-Rats,
pubmed-meshheading:9740395-Rats, Inbred F344
|
pubmed:year |
1998
|
pubmed:articleTitle |
Characterization of human presenilin 1 transgenic rats: increased sensitivity to apoptosis in primary neuronal cultures.
|
pubmed:affiliation |
Rhône-Poulenc Rorer S.A., Research and Development, Vitry sur Seine, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|